ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 761393 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 761393; 2) Community: the network communities that were significantly associated with the response to NSC 761393; 3) Molecule: the relationships between components within communities and NSC 761393; 4) MDR: the compounds that were significantly associated with the NSC 761393.

NSC Compound Enrichment Correlation
NSC 657751 Null 0.0407060322613564 0.30098686
NSC 668419 Null 0.0407060322613564 0.039362507
NSC 671404 Null 0.0407060322613564 0.27625108
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0407060322613564 -0.026376193
NSC 68091 WLN: WS3&1U1SW3 -T 0.0407060322613564 0.1810457
NSC 682298 Camptothecin Derivative 0.0407060322613564 0.35962238
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0407060322613564 0.12829175
NSC 682841 Null 0.0407060322613564 0.24782031
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.0407060322613564 0.32860635
NSC 687002 Null 0.0407060322613564 0.14947224
Total:64  Current:52    [First] [Prev] [Next] [Last]